Associated Papers
Characterization of prevalent genetic variants in the Estonian Biobank body-mass index GWAS.
Abner E et al.
Nature Communications, 2025
Contrastive sequence signatures between the both sides of a recombination spot reveal an adaptation at PPARD locus from standing variation for pleiotropy since out-of-Africa dispersal.
Shou W et al.
Bmc Genomics, 2025
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
Identifying novel regulatory effects for clinically relevant genes through the study of the Greek population.
Rouskas K et al.
Bmc Genomics, 2023
Association of SULT1A2 rs1059491 with obesity and dyslipidaemia in southern Chinese adults.
Lv HY et al.
Scientific Reports, 2023
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries.
Liu Z et al.
Nature Genetics, 2023
Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on Phase II drug metabolism.
Isvoran A et al.
Drug Discovery Today, 2022
Coding Variants are Relevant to the Expression of Obesity-Related Genes for Pediatric Adiposity.
Mao K et al.
Obesity (silver Spring, Md.), 2021
Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting.
Pongor LS et al.
Scientific Reports, 2020
An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn's Disease in Japanese Populations.
Kakuta Y et al.
Scientific Reports, 2020
A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.
Liu Q et al.
Bmc Medical Genetics, 2018
Fine Mapping of a GWAS-Derived Obesity Candidate Region on Chromosome 16p11.2.
Volckmar AL et al.
Plos One, 2015
Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes.
Christodoulou K et al.
Gut, 2013
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
Speliotes EK et al.
Nature Genetics, 2010
Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution.
Hao D et al.
Science China. Life Sciences, 2010
Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.
Ginsberg G et al.
Critical Reviews in Toxicology, 2010
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.
Dunn BK et al.
International Journal of Molecular Epidemiology and Genetics, 2010
Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
Küry S et al.
Bmc Cancer, 2008
Genotyping panel for assessing response to cancer chemotherapy.
Dai Z et al.
Bmc Medical Genomics, 2008
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.
Kim KA et al.
European Journal of Clinical Pharmacology, 2005
A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer.
Landi S et al.
Experimental Lung Research, 2005
Association of the SULT1A1 R213H polymorphism with colorectal cancer.
Wong CF et al.
Clinical and Experimental Pharmacology & Physiology, 2002
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002
Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.
Glatt H et al.
Mutation Research, 2001
Sulfotransferases: genetics and role in toxicology.
Glatt H et al.
Toxicology Letters, 2000
Structural characterization of human aryl sulphotransferases.
Brix LA et al.
The Biochemical Journal, 1999